Q3 Results

Fractal Analytics reported a 10.5% rise in Q3 profit to ₹102.6 crore, with revenue up 21% year-on-year as healthcare, life sciences and BFS demand lifted its first post-listing results

Thus far in the calendar year 2026, BEL has outperformed the market by surging 16%, as compared to 6.6% decline in the BSE Sensex.

Acutaas Chemicals management has revised revenue guidance upwards from 25 per cent to around 30 per cent growth for FY26.

In the past one month, Lupin has outperformed the market by soaring 6 per cent, as against 4.5 per cent decline in the BSE Sensex.

Supported by solid demand, disciplined execution, and capex programs progressing as planned, Sai Life management remains confident in sustaining positive growth momentum.

In the past one month, the realty index has tanked 10 per cent, as against 6 per cent fall in the BSE Sensex.

There are hopes of a turnaround in overall corporate earnings after six quarters of single digit growth

Proptech firm Square Yards posted a 47 per cent year-on-year rise in Q3FY26 revenue, with Ebitda margin at 8 per cent and improved margins across business segments

The stock price of Swiggy slipped 5% and hit an all-time low of ₹285.85 on the BSE in Monday's intra-day, thus fell below its previous record low of ₹297 touched on May 13, 2025.

Out of the international order book of ₹3.57 trillion, around 75 per cent is from the Middle East, L&T said in the Q3 earnings conference call on January 28, 2026.

Fund management at GIFT-IFSC accelerated in FY26 Q3, with higher commitments, rising investor participation and growing traction in newly launched retail schemes

Paint stocks slipped in FY26 Q3 as weak decorative demand, intense competition and rising crude oil prices outweighed hopes of a volume-led recovery

Infrastructure development, housing growth, electrification and the ongoing shift towards organized and compliant products continue to support the demand, said RR Kabel.

The stock price of Lenskart hit a new high of ₹541.45 and was quoting higher for the third straight day, surging 12 per cent during this period.

Investing in the NBFC business is non-core to the telecom business, hence, analysts may consider it a slight negative from a capital allocation perspective.

ICRA expects Sai Life Sciences to maintain strong growth momentum over the medium term on the back of a healthy growth outlook for the industry, good product mix and deepening customer engagement.

Q3FY26 marked a good cyclical improvement in growth, though it may need one or two quarters to call it a decisive earnings inflection, said Vora

Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.

Lupin management remains confident that the India formulations business will continue to outperform IPM by 1.2-1.3 times, supported by strong sales force and pipeline of new product launches.

Tata Steel, JSW Steel and Jindal Steel hit their respective all-time highs on the NSE today